Testing effectiveness (Phase 2)Study completedNCT00217815What this trial is testingPreliminary Study of Mycograb and Docetaxel in Advanced Breast CancerWho this might be right forCancer of the Breast NeuTec Pharma 20
Testing effectiveness (Phase 2)UnknownNCT00026078What this trial is testingDocetaxel and Ifosfamide in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Grupo Oncologico Cooperativo del Sur 42
Not applicableActive Not RecruitingNCT05959291What this trial is testingDiscontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast CancerWho this might be right forHER2-positive Metastatic Breast CancerStage IV Breast Cancer University of Miami 20
Testing effectiveness (Phase 2)Study completedNCT00005991What this trial is testingGemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer M.D. Anderson Cancer Center 76
Post-approval studies (Phase 4)Ended earlyNCT03220178What this trial is testingImpact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine TherapyWho this might be right forBreast Neoplasm Palleos Healthcare GmbH 532
Testing effectiveness (Phase 2)Study completedNCT00003425What this trial is testingPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectWho this might be right forBreast CancerLeukemiaLymphoma+4 more University of Kentucky 25
Testing effectiveness (Phase 2)Study completedNCT00755885What this trial is testingAbiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Cancer Research UK 77
Testing effectiveness (Phase 2)UnknownNCT00404404What this trial is testingABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Premiere Oncology 35
Testing effectiveness (Phase 2)Looking for participantsNCT07612891What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid TumorWho this might be right forBreast Cancer (Locally Advanced or Metastatic)Advanced Solid CancersMetastatic (Stage IV) Breast Cancer+2 more Shenzhen Ionova Life Sciences Co., Ltd.
Early research (Phase 1)Looking for participantsNCT04521764What this trial is testingA Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast Adenocarcinoma+2 more Mayo Clinic 54
Early research (Phase 1)Ended earlyNCT01249443What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionWho this might be right forHIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more AIDS Malignancy Consortium 17
Not applicableLooking for participantsNCT05746325What this trial is testingTumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Leptomeninges+2 more Mayo Clinic 5
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT01042535What this trial is testingVaccine Therapy and 1-MT in Treating Patients With Metastatic Breast CancerWho this might be right forMale Breast CancerRecurrent Breast CancerStage IV Breast Cancer+1 more H. Lee Moffitt Cancer Center and Research Institute 44
Testing effectiveness (Phase 2)Study completedNCT00002585What this trial is testingPyrazoloacridine in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT00003135What this trial is testingWhole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical CancerWho this might be right forBreast CancerCervical CancerEndometrial Cancer+1 more The University of Texas Health Science Center, Houston 34
Testing effectiveness (Phase 2)Study completedNCT03633331What this trial is testingPalbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7 Alliance for Clinical Trials in Oncology 93
Post-approval studies (Phase 4)Not Yet RecruitingNCT06578299What this trial is testingInetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast CancerWho this might be right forBreast Cancer Stage IV Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT03691493What this trial is testingRadiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+4 more Emory University 36
Large-scale testing (Phase 3)Study completedNCT00103233What this trial is testingVinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network